Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Fusion Pharmaceuticals Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +1 vs. Q2 2023
- Shares held
- 49.9M
- −314.3K (−0.6%) vs. Q2 2023
- Total value
- $129.8M
- −$105.0M (−44.7%) vs. Q2 2023
- New holders
- 4
- 8 more added
- Sold out
- 3
- 9 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 79 | $0 | 0.00% | −1,322−94.4% | Reduced |
| JPMorgan Chase & Co | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10 | $26 | 0.00% | −90−90.0% | Reduced |
| Tower Research Capital LLC (TRC) | 139 | $361 | 0.00% | +139 | New |
| Signaturefd, LLC | 300 | $789 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 500 | $1.19K | 0.00% | +500 | New |
| TD Waterhouse Canada Inc. | 700 | $1.68K | 0.00% | 00.0% | Unchanged |
| Dorsey Wright & Associates | 878 | $2.28K | 0.00% | −4,011−82.0% | Reduced |
| Bank of America Corp | 1,547 | $4.02K | 0.00% | −778−33.5% | Reduced |
| Royal Bank of Canada | 4,204 | $11.0K | 0.00% | +2,365+128.6% | Added |
| BlackRock Inc. | 8,253 | $21.5K | 0.00% | 00.0% | Unchanged |
| NEOS Investment Management LLC | 17,493 | $45.5K | 0.01% | +17,493 | New |
| Geode Capital Management, LLC | 30,868 | $80.3K | 0.00% | +494+1.6% | Added |
| Two Sigma Advisers, LP | 32,100 | $83.5K | 0.00% | −33,300−50.9% | Reduced |
| Forefront Analytics, LLC | 33,685 | $87.6K | 0.05% | +13,610+67.8% | Added |
| Leonteq Securities AG | 35,000 | $91.0K | 0.01% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 57,297 | $149.0K | 0.03% | 00.0% | Unchanged |
| Woodline Partners LP | 78,035 | $202.9K | 0.00% | +78,035 | New |
| UBS Group AG | 93,309 | $242.6K | 0.00% | −651−0.7% | Reduced |
| Sofinnova Investments, Inc. | 117,099 | $304.5K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 166,060 | $431.8K | 0.00% | +28,449+20.7% | Added |
| Ghost Tree Capital, LLC | 243,287 | $632.5K | 0.31% | −169,412−41.0% | Reduced |
| Sio Capital Management, LLC | 246,036 | $639.7K | 0.20% | 00.0% | Unchanged |
| UBS Oconnor LLC | 274,568 | $713.9K | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 328,868 | $855.1K | 0.00% | 00.0% | Unchanged |
| Eagle Health Investments LP | 579,769 | $1.51M | 0.33% | −100,601−14.8% | Reduced |
| Millennium Management LLC | 582,129 | $1.51M | 0.00% | +247,552+74.0% | Added |
| 1832 Asset Management L.P. | 734,321 | $1.91M | 0.00% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,354,258 | $3.52M | 0.85% | +25,000+1.9% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4.06M | 1.62% | 00.0% | Unchanged |
| Artal Group S.A. | 1,725,000 | $4.49M | 0.20% | 00.0% | Unchanged |
| TPG GP A, LLC | 2,551,794 | $6.63M | 0.11% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,751,395 | $7.15M | 0.24% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,823,000 | $7.34M | 0.16% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $7.66M | 2.68% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $8.10M | 0.01% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,122,770 | $8.12M | 0.19% | 00.0% | Unchanged |
| Johnson & Johnson | 3,670,516 | $9.54M | 3.52% | 00.0% | Unchanged |
| FMR LLC | 4,177,848 | $10.9M | 0.00% | −503,609−10.8% | Reduced |
| Avidity Partners Management LP | 5,781,850 | $15.0M | 0.61% | +81,850+1.4% | Added |
| Federated Hermes, Inc. | 10,683,789 | $27.8M | 0.07% | +50,000+0.5% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −31,154−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |